The latest issues
Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.
All articles
Global burden of NAFLD and chronic liver disease among adolescents and young adults
Hepatology. 2022;75(5):1204–17
Value of liver biopsy in the diagnosis of drug-induced liver injury
J Hepatol. 2022;76(5):1070–8
Simplified 6-month prediction scores for primary biliary cholangitis patients treated with ursodeoxycholic acid
Eur J Gastroenterol Hepatol. 2022;34(4):411–6
Systematic review of response criteria and end points in autoimmune hepatitis by the International Autoimmune Hepatitis Group
J Hepatol. 2022;76(4):841–9
Outcome of pregnancy in patients with primary sclerosing cholangitis
Dig Liver Dis. 2022;54(4):509–14
Neutrophil-lymphocyte ratio and the risk of 30-day mortality in patients with overt hepatic encephalopathy
Eur J Gastroenterol Hepatol. 2022;34(5):529–36
Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis
J Hepatol. 2022;76(5):1079–89
L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial
Hepatology. 2022;75(5):1194–203
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab versus sorafenib for unresectable hepatocellular carcinoma
J Hepatol. 2022;76(4):862–73